Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Clinical trial NCT05733624 · COMPLETED

Trial details

NCT number: NCT05733624
Sponsor: SCAI Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2023-01-05
Primary completion: 2023-08-23
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.